The study appeared in the Journal of the American Medical Association and prompted the World Health Organization (WHO) to recommend the use of the medicines, known as IL-6 inhibitors, in addition to corticosteroids among patients with severe or critical COVID-19.
View Story
Arthritis drugs tocilizumab and sarilumab reduce COVID-19 deaths: study
No comments yet
